• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用模型降阶技术时简化 QSP 模型的选择和鉴定。

Selection and Qualification of Simplified QSP Models When Using Model Order Reduction Techniques.

机构信息

School of Pharmacy, University of Otago, Dunedin, New Zealand.

Translational Medicine Center, Ono Pharmaceutical Co., Ltd., Osaka, Japan.

出版信息

AAPS J. 2017 Nov 27;20(1):2. doi: 10.1208/s12248-017-0170-9.

DOI:10.1208/s12248-017-0170-9
PMID:29181592
Abstract

Quantitative systems pharmacology (QSP) models are increasingly used in drug development to provide a deep understanding of the mechanism of action of drugs and to identify appropriate disease targets. Such models are, however, not suitable for estimation purposes due to their high dimensionality. Based on any desired and specific input-output relationship, the system may be reduced to a model with fewer states and parameters. However, any simplification process will be a trade-off between model performance and complexity. In this study, we develop a weighted composite criterion which brings together the opposing indices of performance and dimensionality. The weighting factor can be determined by qualification of the simplified model based on a visual predictive check (VPC) using the precision of each parameter. The weighted criterion and model qualification techniques were illustrated with three examples: a simple compartmental pharmacokinetic model, a physiologically based pharmacokinetic (PBPK) example, and a semimechanistic model for bone mineral density. When considering the PBPK example, this automated search identified the same reduced model which had been detected in a previous report, as well as a simpler model which had not been previously identified. The simpler bone mineral density model provided an adequate description of the response even after 1 year from the initiation of treatment. The proposed criterion together with a VPC provides a natural way for model order reduction that can be fully automated and applied to multiscale models.

摘要

定量系统药理学(QSP)模型越来越多地用于药物开发,以提供对药物作用机制的深入了解,并确定适当的疾病靶点。然而,由于其高维性,这些模型不适合用于估计目的。基于任何所需的特定输入-输出关系,系统可以简化为具有更少状态和参数的模型。然而,任何简化过程都将在模型性能和复杂性之间进行权衡。在这项研究中,我们开发了一种加权综合标准,该标准汇集了性能和维度的对立指标。权重因子可以根据简化模型的可视化预测检查(VPC)的资格来确定,该 VPC 使用每个参数的精度来确定。加权标准和模型资格技术通过三个示例进行了说明:一个简单的房室药代动力学模型、一个基于生理学的药代动力学(PBPK)示例和一个用于骨密度的半机械模型。在考虑 PBPK 示例时,这种自动搜索确定了与之前报告中检测到的相同的简化模型,以及之前未检测到的更简单的模型。更简单的骨密度模型甚至在治疗开始 1 年后也能对反应提供足够的描述。所提出的标准结合 VPC 为模型降阶提供了一种自然的方法,该方法可以完全自动化,并应用于多尺度模型。

相似文献

1
Selection and Qualification of Simplified QSP Models When Using Model Order Reduction Techniques.使用模型降阶技术时简化 QSP 模型的选择和鉴定。
AAPS J. 2017 Nov 27;20(1):2. doi: 10.1208/s12248-017-0170-9.
2
Automated Scale Reduction of Nonlinear QSP Models With an Illustrative Application to a Bone Biology System.非线性 QSP 模型的自动尺度缩减及其在骨生物学系统中的应用实例。
CPT Pharmacometrics Syst Pharmacol. 2018 Sep;7(9):562-572. doi: 10.1002/psp4.12324. Epub 2018 Aug 13.
3
Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.整合而非孤立:为药物发现和开发中的定量和系统药理学辩护。
Drug Discov Today. 2011 Dec;16(23-24):1031-6. doi: 10.1016/j.drudis.2011.10.001. Epub 2011 Oct 13.
4
Automated proper lumping for simplification of linear physiologically based pharmacokinetic systems.用于简化基于生理药代动力学线性系统的自动合理归并
J Pharmacokinet Pharmacodyn. 2019 Aug;46(4):361-370. doi: 10.1007/s10928-019-09644-5. Epub 2019 Jun 21.
5
Model reduction in mathematical pharmacology : Integration, reduction and linking of PBPK and systems biology models.数学药理学中的模型简化:PK/PD 模型和系统生物学模型的整合、简化和链接。
J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):537-555. doi: 10.1007/s10928-018-9584-y. Epub 2018 Mar 26.
6
Understanding and reducing complex systems pharmacology models based on a novel input-response index.基于新型输入-响应指标理解和简化复杂系统药理学模型。
J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):139-157. doi: 10.1007/s10928-017-9561-x. Epub 2017 Dec 14.
7
Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.药物研发中的转化定量系统药理学:从现状到良好实践。
AAPS J. 2019 Jun 3;21(4):72. doi: 10.1208/s12248-019-0339-5.
8
Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.药物代谢动力学和定量系统药理学在癌症治疗中的应用:以 luminal A 型乳腺癌为例。
Pharmacol Res. 2017 Oct;124:20-33. doi: 10.1016/j.phrs.2017.07.015. Epub 2017 Jul 19.
9
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.从基础到系统药效动力学模型的转变:皮质类固醇的经验教训。
Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101.
10
A framework for simplification of quantitative systems pharmacology models in clinical pharmacology.临床药理学中定量系统药理学模型简化框架
Br J Clin Pharmacol. 2022 Feb;88(4):1430-1440. doi: 10.1111/bcp.14451. Epub 2020 Jul 14.

引用本文的文献

1
Accelerating virtual patient generation with a Bayesian optimization and machine learning surrogate model.利用贝叶斯优化和机器学习代理模型加速虚拟患者生成
CPT Pharmacometrics Syst Pharmacol. 2025 Mar;14(3):486-494. doi: 10.1002/psp4.13288. Epub 2024 Dec 4.
2
Assessing the performance of QSP models: biology as the driver for validation.评估定量系统药理学(QSP)模型的性能:以生物学作为验证的驱动因素。
J Pharmacokinet Pharmacodyn. 2024 Oct;51(5):533-542. doi: 10.1007/s10928-023-09871-x. Epub 2023 Jun 29.
3
Exploring Inductive Linearization for simulation and estimation with an application to the Michaelis-Menten model.

本文引用的文献

1
Methods of Model Reduction for Large-Scale Biological Systems: A Survey of Current Methods and Trends.大规模生物系统的模型简化方法:当前方法与趋势综述
Bull Math Biol. 2017 Jul;79(7):1449-1486. doi: 10.1007/s11538-017-0277-2. Epub 2017 Jun 27.
2
Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation.定量系统药理学(QSP)模型的方法:设计与估计
CPT Pharmacometrics Syst Pharmacol. 2017 Aug;6(8):496-498. doi: 10.1002/psp4.12206. Epub 2017 Jul 11.
3
Exploring inductive linearization for pharmacokinetic-pharmacodynamic systems of nonlinear ordinary differential equations.
探索用于模拟和估计的归纳线性化及其在米氏模型中的应用。
J Pharmacokinet Pharmacodyn. 2022 Aug;49(4):445-453. doi: 10.1007/s10928-022-09813-z. Epub 2022 Jul 5.
4
Algorithmic multiscale analysis for the FcRn mediated regulation of antibody PK in human.基于算法的多尺度分析研究 FcRn 介导的人源抗体 PK 调控
Sci Rep. 2022 Apr 13;12(1):6208. doi: 10.1038/s41598-022-09846-x.
5
Quantitative system pharmacology as a legitimate approach to examine extrapolation strategies used to support pediatric drug development.定量系统药理学作为一种合法的方法来检验用于支持儿科药物开发的外推策略。
CPT Pharmacometrics Syst Pharmacol. 2022 Jul;11(7):797-804. doi: 10.1002/psp4.12801. Epub 2022 May 24.
6
Two heads are better than one: current landscape of integrating QSP and machine learning : An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learning.两个脑袋总比一个好:整合 QSP 和机器学习的现状:定量系统药理学和机器学习整合工作组的 ISoP QSP SIG 白皮书。
J Pharmacokinet Pharmacodyn. 2022 Feb;49(1):5-18. doi: 10.1007/s10928-022-09805-z. Epub 2022 Feb 1.
7
Reduction of quantitative systems pharmacology models using artificial neural networks.基于人工神经网络的定量系统药理学模型简化。
J Pharmacokinet Pharmacodyn. 2021 Aug;48(4):509-523. doi: 10.1007/s10928-021-09742-3. Epub 2021 Mar 2.
8
Automated Scale Reduction of Nonlinear QSP Models With an Illustrative Application to a Bone Biology System.非线性 QSP 模型的自动尺度缩减及其在骨生物学系统中的应用实例。
CPT Pharmacometrics Syst Pharmacol. 2018 Sep;7(9):562-572. doi: 10.1002/psp4.12324. Epub 2018 Aug 13.
探索非线性常微分方程药代动力学-药效学系统的归纳线性化。
J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):35-47. doi: 10.1007/s10928-017-9527-z. Epub 2017 May 26.
4
A combined model reduction algorithm for controlled biochemical systems.一种用于受控生化系统的组合模型约简算法。
BMC Syst Biol. 2017 Feb 13;11(1):17. doi: 10.1186/s12918-017-0397-1.
5
Recent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory Acceptance.基于生理的药代动力学(PBPK)模型的开发与应用的最新进展:从学术好奇到监管认可的转变
Curr Pharmacol Rep. 2016;2(3):161-169. doi: 10.1007/s40495-016-0059-9. Epub 2016 Apr 14.
6
Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers.一项在健康志愿者中进行的人重组碱性磷酸酶随机、双盲、安慰剂对照试验中的药代动力学建模与剂量选择
Clin Pharmacokinet. 2016 Oct;55(10):1227-1237. doi: 10.1007/s40262-016-0399-y.
7
Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data.简化基于生理的全身药代动力学模型以稳定临床数据的贝叶斯分析
AAPS J. 2016 Jan;18(1):196-209. doi: 10.1208/s12248-015-9840-7. Epub 2015 Nov 4.
8
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics.贝叶斯方法在吗啉硝唑群体药代动力学生理模型中的应用。
J Pharmacokinet Pharmacodyn. 2015 Dec;42(6):639-57. doi: 10.1007/s10928-015-9430-4. Epub 2015 Aug 1.
9
FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?美国食品药品监督管理局咨询会议临床药理学审查采用定量系统药理学(QSP)模型:一个分水岭时刻?
CPT Pharmacometrics Syst Pharmacol. 2015 Mar;4(3):e00020. doi: 10.1002/psp4.20. Epub 2015 Mar 12.
10
A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling.基于骨重塑循环模型的骨矿物质密度和骨转换半机制模型。
J Pharmacokinet Pharmacodyn. 2015 Aug;42(4):315-32. doi: 10.1007/s10928-015-9423-3. Epub 2015 Jun 30.